About Aurie
Aurie is a Healthcare company based in New York (United States) founded in 2017 by Marjorie Nelson, Daniel Wollin, and Souvik Paul. Automated reusable self-catheter systems are developed for urinary retention patients. Aurie has raised $12.23 million across 2 funding rounds from investors including Lakehouse Ventures. The company has 4 employees. Its chief executive, as recorded, is Souvik Paul. Aurie offers products and services including Reusable Catheter System. Its focus areas include Life Sciences, Genitourinary Disorders, Medical Devices and Therapeutics. Its competitors include NanoVibronix and BioDerm; 1 of its 2 listed competitors has raised funding.
Company details
Aurie was established in 2017 in New York, United States, within the medical device sector. Focus is placed on the creation of a reusable intermittent urinary catheter system. This technology is designed for rehabilitation among spinal cord injury patients and management of urinary retention conditions. Operations involve engineering an automated self-catheter solution to support user independence in daily care routines.
- Headquarters New York, United States
- Employees 4
- Founders Marjorie Nelson, Daniel Wollin, Souvik Paul
- SectorsHealthcare
- Website livewithaurie.com
- Social LinkedIn
- Total Equity Funding$12.23M (USD)
in 2 rounds
- Latest Funding Round$6M (USD), Series A
Apr 2024
- Investors
- Employee Count4
Products & Services of Aurie
Aurie offers a comprehensive portfolio of products and services, including Reusable Catheter System.
No-touch system for safe, hygienic catheterization to support independence and health.
Funding Insights of Aurie
Aurie has successfully raised a total of $12.23M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $6 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $12.23M
- Total Rounds 2
- Last Round Series A — $6M
- First Round $6.23M
(Feb 2023)
- Investors Count 1
All 2 funding rounds of Aurie with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2024 | $6M | Series A | – | Lakehouse Ventures | – |
| Feb 2023 | $6.23M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in Aurie
Aurie has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Lakehouse Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A pre-seed venture capital firm is operated for innovative founders. | lakehouse.vc |
Investor details for Aurie
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Aurie
5 people are tracked at Aurie (5 in leadership); the tracked headcount is 4.
| Name | Role | Group |
|---|---|---|
Marjorie Nelson | Co-Founder | Leadership |
Daniel Wollin | Co-Founder | Leadership |
Souvik Paul | Co-Founder & CEO | Leadership |
Marjorie Nelson, MBA | Co-founder, Chief Operating Officer | Leadership |
Sergey Grigoryants | VP of Engineering | Leadership |
Complete people profiles for Aurie
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Aurie
3 dated milestones of Aurie across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Aurie is founded.
- Funding First funding round of $6.2M.
- Funding Latest funding round, Series A, of $6.0M.
Competitors of Aurie
Aurie has 2 listed competitors in our database, 1 of them funded. They include NanoVibronix and BioDerm.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nanovibronix.com | 2003 | Elmsford, United States | $10.89M | 10 | Provider of ultrasound therapy devices for multiple health purposes | |
| bioderminc.com | 1991 | Largo, United States | 73 | Hydrocolloid products are developed for urinary management and skin protection. |
Detailed competitors of Aurie
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genitourinary Disorders
3 companies that operate in the same segment as Aurie (Genitourinary Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | |||
Provider of surgical devices for vertical hernia repair and abdominal wall reconstruction | 2012 | Malvern, Pennsylvania, United States | USD 104.6 M | USD 80.28 M | 209 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aurie
Aurie was founded in 2017 and raised its 1st funding round 6 years after it was founded.
Aurie is headquartered in New York, United States. It is registered at New York, New York, United States.
Souvik Paul is the CEO of Aurie, as recorded in our data. They have also founded this company.
Aurie is a funded company, having raised a total of $12.23M across 2 funding rounds to date. The company's 1st funding round was a Series A of $6.23M, raised on Feb 2023.
Aurie has 4 employees.
Aurie was established in 2017 in New York, United States, within the medical device sector. Focus is placed on the creation of a reusable intermittent urinary catheter system. This technology is designed for rehabilitation among spinal cord injury patients and management of urinary retention conditions. Operations involve engineering an automated self-catheter solution to support user independence in daily care routines.
Aurie's top competitors include NanoVibronix and BioDerm.
Aurie offers Reusable Catheter System.
Aurie has 1 investor. Key investors include Lakehouse Ventures.